8-KLeadership ChangesExhibits & Filings

ELI LILLY & Co 8-K Report, Executive Changes (Aug 17, 2021)

Filed August 17, 2021For Securities:LLY

Summary

Eli Lilly and Company (LLY) announced on August 17, 2021, that Alfonso Zulueta, Senior Vice President and President of Lilly International, will retire effective December 26, 2021. This leadership transition is a significant event for the company, as Mr. Zulueta has held a key role in the company's international operations. Investors should monitor the company's strategic succession planning and how this change might impact Lilly's global market performance and future growth initiatives. The announcement was made via a press release filed as part of an 8-K filing. While the filing primarily details Mr. Zulueta's upcoming retirement, it also references other corporate changes mentioned in the press release. Investors are encouraged to review the full press release (Exhibit 99.1) for comprehensive details on any additional organizational adjustments that may affect the company's operational structure and future outlook.

Key Highlights

  • 1Alfonso Zulueta, SVP and President of Lilly International, to retire on December 26, 2021.
  • 2Retirement announcement made on August 17, 2021, via an 8-K filing.
  • 3The filing includes a press release (Exhibit 99.1) detailing the retirement and other corporate changes.
  • 4Investors should pay attention to potential impacts on the company's international business segment.
  • 5This event signifies a key leadership transition within Eli Lilly and Company.

Frequently Asked Questions

Alfonso Zulueta is the Senior Vice President and President of Lilly International at Eli Lilly and Company. He has been responsible for the company's operations and strategic direction in international markets.

Mr. Zulueta's retirement will be effective as of December 26, 2021.

Mr. Zulueta's retirement marks a significant leadership change, particularly for Eli Lilly's international business. Investors may want to assess the company's succession plan for this critical role and consider any potential impact on the performance and growth strategies of Lilly's international segment. The press release accompanying the filing may offer further insights into these areas.

The 8-K filing states that the press release announcing Mr. Zulueta's retirement also included 'certain other corporate changes.' Investors should refer to Exhibit 99.1 (the press release) for complete details on any other organizational adjustments or announcements.